Sign in

CIK 0001867096 · Large accelerated filer

Xeris Biopharma Holdings, Inc.

Sign in to watch
Ticker
XERS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
871082097
Phone
844-445-5704
Business address
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,678,894
in 11 filings, $1.7M under 10b5-1 plans

Net −$1,678,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. McCulloch Kevin −$984K See Remarks sold 6% of stake
  2. Hecht Beth −$554K See Remarks sold 5% of stake
  3. Pieper Steven −$141K See Remarks sold 1% of stake
Date Insider Transaction Shares Price Value Owned after
2022-01-29 Hecht Beth See Remarks Shares withheld for taxes −14,037 $2.11 $30K 1,544,771
2022-01-29 JOHNSON KENNETH ERLAND See Remarks Shares withheld for taxes −7,497 $2.11 $16K 440,443
2022-01-29 Pieper Steven See Remarks Shares withheld for taxes −3,460 $2.11 $7K 1,623,452
2022-01-29 Shannon John Patrick Jr See Remarks Shares withheld for taxes −15,692 $2.11 $33K 2,403,920
2022-01-03 Pieper Steven See Remarks Grant or award +200,000 388,834
2022-01-03 JOHNSON KENNETH ERLAND See Remarks Grant or award +75,000 165,865
2022-01-03 Hecht Beth See Remarks Grant or award +225,000 436,821
2022-01-03 Shannon John Patrick Jr See Remarks Grant or award +250,000 618,910
2022-01-03 Edick Paul R See Remarks Grant or award +600,000 1,408,064
2022-01-03 PRESTRELSKI STEVEN Chief Scientific Officer Grant or award +75,000 569,780
2021-11-15 Edick Paul R See Remarks Purchase +20,000 $2.28 $46K 33,430
2021-11-12 Shannon John Patrick Jr See Remarks Purchase +60,000 $2.10 $126K 363,829
2021-11-11 Shannon John Patrick Jr See Remarks Purchase +40,000 $2.09 $84K 303,829
2021-11-11 Edick Paul R See Remarks Purchase +200,000 $2.08 $416K 808,064
2021-11-10 Pieper Steven See Remarks Purchase +25,000 $2.00 $50K 183,108
2021-10-05 Kong Garheng Director Grant or award +50,170 50,170
2021-10-05 Kong Garheng Director Grant or award · Stock Option (Right to Buy) +19,600 19,600
2021-10-05 Kong Garheng Director Grant or award · Stock Option (Right to Buy) +7,357 7,357
2021-10-05 Kong Garheng Director Grant or award · Stock Option (Right to Buy) +31,360 31,360
2021-10-05 Kong Garheng Director Grant or award · Stock Option (Right to Buy) +31,360 31,360

Page 13 of 18 · 354 trades